癌症中性粒细胞:从生物学到治疗
Leo Koenderman1, Nienke Vrisekoop2
1Dept. Respiratory Medicine and Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands. l.koenderman@umcutrecht.nl.
Cellular & molecular immunology
|December 9, 2024
概括
中性粒细胞曾经被视为简单的病原体战斗剂,现在被理解为参与组织修复的复杂免疫调节剂. 它们在健康和疾病 (包括癌症) 中的双重作用凸显了影响治疗的"混乱状态".
科学领域:
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
- 在瘤学瘤学.
背景情况:
- 中性粒细胞 (多态核白细胞) 越来越多地被认为具有超出病原体清除的作用.
- 这些细胞对于维持组织平衡和免疫调节至关重要.
- 中性粒细胞的功能取决于环境,表现出有益和有害的影响.
研究的目的:
- 审查中性粒细胞在健康和疾病中的多方面的作用.
- 探索中性粒细胞在瘤免疫学中的双重亲和抗瘤原生功能.
- 在中性粒细胞驱动的反应中引入混乱状态的概念.
主要方法:
- 对中性粒细胞功能当前研究的文献综述.
- 对调查中性粒细胞参与免疫调节和组织修复的研究进行分析.
- 检查中性粒细胞的原源和抗源性质的证据.
主要成果:
- 中性粒细胞具有强大的抗微生物功能,但可以导致宿主组织损伤.
- 不同的中性粒细胞亚型表现出各种各样的作用,包括免疫抑制和组织愈合.
- 中性粒细胞在癌症免疫学中表现出支持和抗瘤的活性.
结论:
- 中性粒细胞是复杂的细胞,在免疫调节和组织平衡中起着重要作用.
- 它们的双重性在癌症治疗中带来了挑战和机遇.
- 了解中性粒细胞反应的"混乱状态"对于开发有效的治疗方法至关重要.
相关概念视频
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Tumor Immunotherapy
476
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
476


